CME Group FY2025 EPS Estimate Increased by Zacks Research

Key Points

• Zacks Research raised its FY2025 earnings per share estimate for CME Group from $10.98 to $11.13, indicating positive expectations for the financial services provider.
• Multiple analysts have increased their price targets for CME Group's stock, with the highest target now set at $303.00 by Oppenheimer.
• CME Group recently announced a quarterly dividend of $1.25, representing an annual yield of 1.8%, with a payout ratio of 48.40%.

CME Group Inc. (NASDAQ:CME - Free Report) - Stock analysts at Zacks Research boosted their FY2025 earnings per share estimates for shares of CME Group in a report issued on Tuesday, August 12th. Zacks Research analyst T. De now anticipates that the financial services provider will post earnings of $11.13 per share for the year, up from their previous estimate of $10.98. The consensus estimate for CME Group's current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group's Q2 2026 earnings at $2.94 EPS, Q3 2026 earnings at $2.68 EPS, Q4 2026 earnings at $3.02 EPS, FY2026 earnings at $11.50 EPS and FY2027 earnings at $12.37 EPS.

Other equities research analysts have also issued research reports about the company. Piper Sandler boosted their price target on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Oppenheimer upped their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Keefe, Bruyette & Woods increased their price target on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. JPMorgan Chase & Co. lowered their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Finally, Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, CME Group has an average rating of "Hold" and a consensus price target of $261.93.

CME Group Stock Performance

Shares of CME stock opened at $275.88 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock's 50-day moving average price is $275.61 and its 200 day moving average price is $266.55. CME Group has a 52-week low of $204.16 and a 52-week high of $290.79. The stock has a market capitalization of $99.42 billion, a PE ratio of 26.71, a price-to-earnings-growth ratio of 5.07 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.56 EPS.

Institutional Investors Weigh In On CME Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Webster Bank N. A. lifted its position in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after buying an additional 60 shares in the last quarter. Highline Wealth Partners LLC lifted its position in CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock worth $26,000 after buying an additional 43 shares in the last quarter. Wayfinding Financial LLC bought a new stake in CME Group during the 1st quarter worth about $25,000. Cornerstone Planning Group LLC lifted its position in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after buying an additional 55 shares in the last quarter. Finally, Trifecta Capital Advisors LLC increased its stake in shares of CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider's stock worth $31,000 after purchasing an additional 42 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director William R. Shepard acquired 256 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The shares were acquired at an average cost of $270.53 per share, with a total value of $69,255.68. Following the transaction, the director owned 258,196 shares of the company's stock, valued at $69,849,763.88. The trade was a 0.10% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the sale, the director directly owned 3,108 shares in the company, valued at $863,651.04. This trade represents a 25.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,750 shares of company stock worth $1,576,294 in the last ninety days. 0.30% of the stock is owned by insiders.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group's dividend payout ratio is currently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.